Curexsys Appoints Christian Eckert as Chief Operating Officer
- Strengthened management team headed by Jörg Neermann as CEO Goettingen, Germany, October 20, 2021 - Curexsys GmbH, a leader in the emerging field [...]
- Strengthened management team headed by Jörg Neermann as CEO Goettingen, Germany, October 20, 2021 - Curexsys GmbH, a leader in the emerging field [...]
Curexsys acquires a family of patents (EP2195430 & EP 3199633, US8729038 & US9951329, CA2699638, JP2010538625) enabling both targeted delivery of therapeutics and transfer of [...]
Curexsys researchers contribute to two studies that will be presented at the annual meeting of the European Society for Cell and Gene Therapy (ESGCT [...]
Göttingen, Germany, May 1, 2021 – Curexsys GmbH, a new, pre-clinical stage therapeutic company developing iMSC derived exosomes for age-related diseases and anti-aging therapies, [...]
Göttingen, Germany, April 1, 2021 – Curexsys GmbH, a new, pre-clinical stage therapeutic company developing iMSC derived exosomes for age-related diseases and anti-aging therapies, [...]
Evotec and Sartorius partner with Start-Up Curexsys on iPSC-based therapeutic exosome approach. Download Press Release